123 related articles for article (PubMed ID: 11601033)
1. [In vivo migration and survival of donor-derived dendritic cell progenitors genetically modified using an adenoviral vector encoding cDNA for TGF beta 1].
Zhong C; Li WZ; Lü L
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):174-7. PubMed ID: 11601033
[TBL] [Abstract][Full Text] [Related]
2. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.
Lee WC; Zhong C; Qian S; Wan Y; Gauldie J; Mi Z; Robbins PD; Thomson AW; Lu L
Transplantation; 1998 Dec; 66(12):1810-7. PubMed ID: 9884280
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
4. [Transforming growth factor-beta 1 inhibits the generation of dendritic cells from murine hematopoietic progenitor cells in vitro].
Zhang Y; Chen P; Zhang Y
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):178-80. PubMed ID: 11601034
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
[TBL] [Abstract][Full Text] [Related]
6. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
Weber F; Byrne SN; Le S; Brown DA; Breit SN; Scolyer RA; Halliday GM
Cancer Immunol Immunother; 2005 Sep; 54(9):898-906. PubMed ID: 15776284
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
Lee WC; Qiani S; Wan Y; Li W; Xing Z; Gauldie J; Fung JJ; Thomson AW; Lu L
Immunology; 2000 Oct; 101(2):233-41. PubMed ID: 11012777
[TBL] [Abstract][Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
10. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2.
Gorczynski RM; Bransom J; Cattral M; Huang X; Lei J; Xiaorong L; Min WP; Wan Y; Gauldie J
Clin Immunol; 2000 Jun; 95(3):182-9. PubMed ID: 10866124
[TBL] [Abstract][Full Text] [Related]
11. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells induced in the presence of GM-CSF and IL-5.
Yi H; Zhang L; Zhen Y; He X; Zhao Y
Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
[TBL] [Abstract][Full Text] [Related]
13. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
[TBL] [Abstract][Full Text] [Related]
14. [Effects of TGF-beta1, gene modified donor dendritic cells on immune repulsion].
Liu N; Duan TD; Zheng N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):721-5. PubMed ID: 17037736
[TBL] [Abstract][Full Text] [Related]
15. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
[TBL] [Abstract][Full Text] [Related]
16. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.
Oberholzer A; Oberholzer C; Efron PA; Scumpia PO; Uchida T; Bahjat K; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Tsai V; Hutchins B; Moldawer LL; Laface D; Clare-Salzler MJ
Shock; 2005 Jun; 23(6):507-15. PubMed ID: 15897802
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
[TBL] [Abstract][Full Text] [Related]
18. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
